萬城控股(02892.HK)擬向瑞迅配發2.9億股 籌資3.335億港元
格隆匯9月9日丨萬城控股(02892.HK)發佈公吿,於2021年9月9日,公司與瑞迅訂立認購協議,據此,瑞迅有條件同意認購,且公司有條件同意以每股不可轉換優先股1.15港元(較9月9日收市價每股普通股1.07港元溢價約7.48%)的認購價向瑞迅配發及發行2.9億股不可轉換優先股,總認購金額為3.335億港元。
經扣除認購事項附帶的所有相關開支後,發行不可轉換優先股的所得款項淨額估計約為3.33億港元。集團擬將認購事項的所得款項淨額用作業務發展用途。
董事認為,認購事項將支持集團在目標市場的物業開發的長期增長。認購事項所得款項淨額將增強集團的財務資源,有助於集團進一步發展可能不時獲取的房地產開發業務機會,從而持續提高盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.